BlackRock Crosses Key Ownership Threshold in Orion Corporation

ESPOO, Finland — June 2026: Orion Corporation has announced that it has received an official shareholder disclosure from BlackRock, Inc., one of the world's largest asset management companies, after the investment firm's holdings in Orion exceeded the regulatory reporting threshold of 5% of the company's total shares.

The disclosure was made in accordance with Finland's Securities Market Act, which requires investors to notify both the company and the market whenever ownership crosses specific thresholds. The notification confirms that BlackRock and its affiliated funds increased their combined ownership position in Orion Corporation on June 4, 2026, resulting in total holdings exceeding the 5% level.

Regulatory Filing Highlights Increased Ownership

According to the filing, the total number of shares owned directly and indirectly by BlackRock and its managed funds rose above the mandatory disclosure threshold. The notification also includes holdings obtained through certain financial instruments, which are required to be reported under Finnish securities regulations.

The reported ownership structure shows that BlackRock's combined shareholding and financial instrument exposure now represents approximately 5.06% of Orion Corporation's total shares. The increase triggered an obligation to disclose the position publicly, providing transparency to investors and market participants.

Breakdown of BlackRock's Holdings

The filing details BlackRock's ownership as follows:

Direct and Indirect Share Ownership

BlackRock and its affiliated investment funds hold approximately 7,070,047 Orion shares through indirect ownership structures. These holdings account for approximately 5.00% of Orion's outstanding shares.

Financial Instruments

In addition to direct and indirect share ownership, BlackRock maintains exposure through financial instruments representing approximately 78,771 shares. These instruments include:

• American Depositary Receipts (ADRs)
• Contracts for Difference (CFDs)

Together, these instruments account for an additional 0.05% of Orion's share capital.

When combined with BlackRock's direct and indirect holdings, the firm's total economic exposure reaches approximately 5.06% of Orion Corporation.

Why the 5% Threshold Matters

Ownership disclosure thresholds are an important feature of securities regulation in Europe and many global financial markets. These rules are designed to provide transparency regarding significant shareholders and help investors understand who has meaningful influence within publicly traded companies.

When an investor's holdings cross a specified threshold—whether upward or downward—the event must typically be reported. Such disclosures allow shareholders, analysts, and regulators to monitor ownership changes and assess potential impacts on corporate governance and strategic decision-making.

In Orion's case, BlackRock's position moving above 5% represents a notable development because it establishes the asset management giant as a significant shareholder in the pharmaceutical company.

About Orion Corporation

Orion Corporation is a leading Nordic pharmaceutical company with a history spanning more than a century. Headquartered in Espoo, Finland, the company develops, manufactures, and markets a wide range of pharmaceutical products for both human and veterinary healthcare.

The company is known for combining scientific expertise with ongoing innovation across multiple therapeutic areas. Orion's portfolio includes:

• Prescription medicines
• Generic pharmaceuticals
• Consumer health products
• Veterinary medicines
• Active pharmaceutical ingredients (APIs)

Its research and development activities focus particularly on:

• Oncology (cancer treatments)
• Pain management
• Respiratory diseases
• Neurological disorders

Over the years, Orion has established a strong presence across international healthcare markets while maintaining its roots in the Nordic region.

Strong Financial Performance Supports Investor Interest

The increased ownership disclosure comes at a time when Orion continues to demonstrate solid business performance. According to company information, Orion generated net sales of approximately EUR 1.89 billion during 2025.

The company employs around 4,000 professionals worldwide, supporting research, manufacturing, commercialization, and corporate operations across multiple markets.

Investors have closely followed Orion's progress in expanding its pharmaceutical portfolio, advancing research programs, and strengthening its position within specialized therapeutic areas.

What BlackRock's Investment Could Signal

BlackRock is widely recognized as one of the largest institutional investors globally, managing trillions of dollars in assets across equity, fixed-income, and alternative investment strategies.

While the disclosure does not provide specific reasons behind the increase in ownership, market observers often view growing positions by major institutional investors as a sign of confidence in a company's long-term prospects.

Institutional investors such as BlackRock typically evaluate a range of factors before increasing their exposure to a company, including:

• Financial performance
• Growth opportunities
• Industry outlook
• Research and development pipeline
• Corporate governance practices
• Long-term shareholder value potential

However, regulatory disclosures themselves do not indicate investment intentions, strategic objectives, or future plans regarding the issuer.

Market Transparency and Investor Confidence

Disclosure requirements under securities laws serve a critical role in maintaining transparent and efficient capital markets. By publicly reporting major ownership changes, companies help ensure that all market participants have access to the same material information.

For investors monitoring Orion Corporation, BlackRock's increased position provides additional insight into the company's shareholder base and institutional ownership profile.

Such disclosures contribute to market confidence by ensuring that significant changes in ownership are communicated promptly and accurately.

Corporate Statement

Orion Corporation confirmed that it received the notification in accordance with the Securities Market Act and subsequently released the information through its official stock exchange announcement procedures.

The disclosure was issued under the supervision of Orion's executive management and legal team, reflecting the company's commitment to compliance with Finnish market regulations and investor communication standards.

Looking Ahead

The crossing of the 5% ownership threshold by BlackRock represents an important milestone in Orion Corporation's shareholder structure. While the disclosure does not alter Orion's operations, strategy, or governance framework, it highlights growing institutional participation in the company's ownership base.

As Orion continues to advance its pharmaceutical research programs, expand commercial activities, and pursue long-term growth opportunities, investors will continue monitoring ownership developments and institutional investment trends surrounding the company.

Source: Orion Corporation shareholder disclosure under the Finnish Securities Market Act regarding BlackRock's ownership position exceeding the 5% reporting threshold on June 4, 2026.

#BlackRock #OrionCorporation #PharmaceuticalIndustry #StockMarketNews #SlimScan #GrowthStocks #CANSLIM